MedTrace Logo

Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD

NCT00529893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-05-07

No results posted yet for this study

Summary

The purpose of this study is examine the efficacy of atomoxetine on executive functioning measures including the Continuous Performance Test (CPT) and the executive function measures of the Cambridge Automated Neuropsychological Test Automated Battery (CANTAB).

Conditions

  • Attention Deficit Disorder With Hyperactivity

Sponsors & Collaborators

Principal Investigators

  • Susan Shur-Fen Gau, MD, PhD · Dept of Psychiatry, National Taiwan University Hospital

Eligibility

Min Age
10 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00529893 on ClinicalTrials.gov